Development of Fulminant Type 1 Diabetes Mellitus in the Course of Treatment with Atezolizumab for Hepatocellular Carcinoma

Munehiro Ikeda(Takatsuki Red Cross Hospital), Naoki Kanda(Jichi Medical University), Takashi Tamada(Takatsuki Red Cross Hospital), Risa Takebayashi(Takatsuki Red Cross Hospital), Taishiro Matsumura(Takatsuki Red Cross Hospital), Shohei Nakamori(Takatsuki Red Cross Hospital), Shizuka Kaneko(Japanese Red Cross Society Wakayama Medical Center), Gaku Okuno(Takatsuki Red Cross Hospital), Takuto Yoshioka(Takatsuki Red Cross Hospital), Iori Yagura(Takatsuki Red Cross Hospital)
Internal Medicine
October 25, 2022
Cited by 4


Related Papers